These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3798343)

  • 21. [Frequency and prognostic value of the "e" system in hepatitis B virus infection].
    Onesciuc C; Onesciuc I; Jebeleanu L; Serban I; Gorgan V; Cîrstina D; Oprean N; Feticu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1980; 25(3):175-8. PubMed ID: 7433816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HBeAg and anti-HBe antibodies in chronic liver diseases].
    Bereszyńska I; Juszczyk J; Kryska A; Kaczmarek Z; Krajewski P
    Pol Tyg Lek; 1987 Apr; 42(14):409-12. PubMed ID: 3615268
    [No Abstract]   [Full Text] [Related]  

  • 25. [Selected indicators of hepatitis B in the blood serum during the first few days of hospitalization of patients with acute viral hepatitis].
    Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
    Ann Univ Mariae Curie Sklodowska Med; 1987; 42():83-7. PubMed ID: 3154900
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J; Chlumská A; Zichová M; Helm R; Mankovecký L; König J
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between HBeAg/anti-HBe and other hepatitis B virus (HBV) markers in healthy carriers.
    Musca A; Cordova C; Barnaba V; Zaccari C
    Quad Sclavo Diagn; 1981 Sep; 17(3):363-9. PubMed ID: 7343989
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognostic significance and clinical course of chronic delta-positive hepatitis in children (comparison with chronic delta-negative hepatitis in childhood and delta-positive forms in adults)].
    Calzia R; Navone C; Ciravegna B; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C
    G Clin Med; 1984; 65(5-6):255-60. PubMed ID: 6468807
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P; Trepo C; Brette R; Chevallier P; Vitviski L; Sepetjan M
    Nouv Presse Med; 1981 May; 10(24):1993-6. PubMed ID: 7255135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the HBeAg/anti-HBe system in hepatitis B infection.
    Frösner GG
    Riv Emoter Immunoematol; 1980; 27(1-2):85-7. PubMed ID: 7466190
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
    Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
    Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
    [No Abstract]   [Full Text] [Related]  

  • 36. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
    Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
    Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 38. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
    Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
    Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular cytotoxicity against autologous hepatocytes in chronic hepatitis B--its relationship to the HBeAg/anti-HBe status.
    Poralla T; Hütteroth TH; Staritz M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Apr; 23(4):183-7. PubMed ID: 4060809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.